Literature DB >> 21269006

The relationship between opioid and sugar intake: review of evidence and clinical applications.

David J Mysels1, Maria A Sullivan.   

Abstract

Opioid dependence poses significant public health risks arising from associated morbidity and mortality caused by accidents, infectious diseases, and social ramifications of crime and unemployment, among other complications. Opioid use, acute and chronic, is also associated with weight gain, glycemic dysregulation, and dental pathology. The literature supporting the connection between opiate use and development of preference for sweet tastes is reviewed, and further association with dental pathology, weight gain, and loss of glycemic control are considered. Additionally, the impact of sweet tastes on the endogenous opioid system, as pertaining to analgesia, is also discussed. The authors discuss the clinical implications in relation to the aforementioned conditions while treating the opiate-dependent patient.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21269006      PMCID: PMC3109725          DOI: 10.5055/jom.2010.0043

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  77 in total

1.  Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats.

Authors:  A E Kelley; E P Bless; C J Swanson
Journal:  J Pharmacol Exp Ther       Date:  1996-09       Impact factor: 4.030

2.  Antinociceptive effects of palatable sweet ingesta on human responsivity to pressure pain.

Authors:  M E Mercer; M D Holder
Journal:  Physiol Behav       Date:  1997-02

3.  Effect of methadone addiction on glucose metabolism in rats.

Authors:  D Sadava; D Alonso; H Hong; D P Pettit-Barrett
Journal:  Gen Pharmacol       Date:  1997-01

4.  The response of crying newborns to sucrose: is it a "sweetness" effect?

Authors:  R G Barr; M S Pantel; S N Young; J H Wright; L A Hendricks; R Gravel
Journal:  Physiol Behav       Date:  1999-05

5.  Nonketotic hyperglycemic coma in toddlers after unintentional methadone ingestion.

Authors:  Sinan Tiras; Vincent Haas; Laurent Chevret; Marion Decobert; Anne Buisine; Denis Devictor; Philippe Durand; Pierre Tissières
Journal:  Ann Emerg Med       Date:  2006-04-19       Impact factor: 5.721

Review 6.  Opioid-induced gastrointestinal dysfunction.

Authors:  Sangeeta R Mehendale; Chun-Su Yuan
Journal:  Dig Dis       Date:  2006       Impact factor: 2.404

7.  "Sucrose analgesia": absorptive mechanism or taste perception?

Authors:  L A Ramenghi; D J Evans; M I Levene
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

8.  Assessment of daily nutrition ratios of opiate-dependent persons before and after 4 years of methadone maintenance treatment.

Authors:  Emilia Kolarzyk; Jan Chrostek Maj; Dorota Pach; Anna Janik; Jacek Kwiatkowski; Magdalena Szurkowska
Journal:  Przegl Lek       Date:  2005

9.  Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects.

Authors:  L De Marinis; A Mancini; D Valle; A Bianchi; A M De Luca; A M Fulghesu; P Villa; S Mancuso; A Lanzone
Journal:  Int J Obes Relat Metab Disord       Date:  1997-11

10.  Taste conditioning effects of buprenorphine in morphine-naive and morphine-experienced rats.

Authors:  M Gaiardi; C Gubellini; M Bartoletti
Journal:  Pharmacol Res       Date:  1998-04       Impact factor: 7.658

View more
  29 in total

Review 1.  Effect of taste sensation on cough reflex sensitivity.

Authors:  Paul M Wise; Paul A S Breslin; Pamela Dalton
Journal:  Lung       Date:  2013-10-31       Impact factor: 2.584

2.  Opioid use disorder and type 2 diabetes mellitus: Effect of participation in buprenorphine-naloxone substitution programs on glycemic control.

Authors:  Devon Tilbrook; Jeffrey Jacob; Pierre Parsons; Craig Edwards; Kassandra Loewen; Len Kelly
Journal:  Can Fam Physician       Date:  2017-07       Impact factor: 3.275

3.  Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support.

Authors:  Dharushana Muthulingam; Joshua Bia; Lynn M Madden; Scott O Farnum; Declan T Barry; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2019-01-26

Review 4.  Substance Use Disorders among Patients with Type 2 Diabetes: a Dangerous but Understudied Combination.

Authors:  Kimberly N Walter; Julie A Wagner; Eda Cengiz; William V Tamborlane; Nancy M Petry
Journal:  Curr Diab Rep       Date:  2017-01       Impact factor: 4.810

5.  Is biological aging accelerated in drug addiction?

Authors:  Keren Bachi; Salvador Sierra; Nora D Volkow; Rita Z Goldstein; Nelly Alia-Klein
Journal:  Curr Opin Behav Sci       Date:  2017-02

6.  Sweet taste pleasantness is modulated by morphine and naltrexone.

Authors:  Marie Eikemo; Guro E Løseth; Tom Johnstone; Johannes Gjerstad; Frode Willoch; Siri Leknes
Journal:  Psychopharmacology (Berl)       Date:  2016-08-18       Impact factor: 4.530

7.  Increases in body mass index following initiation of methadone treatment.

Authors:  Jennifer M Fenn; Jennifer S Laurent; Stacey C Sigmon
Journal:  J Subst Abuse Treat       Date:  2014-11-05

8.  Additive burdens of malnutrition, poverty, and substance abuse.

Authors:  Stacey C Sigmon
Journal:  Lancet       Date:  2016-10-15       Impact factor: 79.321

9.  Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake.

Authors:  Anna K Radke; Nathan A Holtz; Jonathan C Gewirtz; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2012-12-20       Impact factor: 4.530

10.  Inflated reward value in early opiate withdrawal.

Authors:  Kate M Wassum; Venuz Y Greenfield; Kay E Linker; Nigel T Maidment; Sean B Ostlund
Journal:  Addict Biol       Date:  2014-07-31       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.